Adam H. Buchanan

5.6k citations

77 papers · 2.0k indexed · 1 hit paper · h-index 24

Genetics top 1%
- BRCA gene mutations in cancer 45
- Genomics and Rare Diseases 23
Cancer Research top 5%
- Cancer Genomics and Diagnostics 8
Pathology and Forensic Medicine top 5%
- Genetic factors in colorectal cancer 17
Oncology top 5%
- Colorectal Cancer Screening and Detection 13
- Global Cancer Incidence and Screening 13
Reproductive Medicine top 5%
Public Health, Environmental and Occupational Health
- Ethics in Clinical Research 14
Economics and Econometrics
- Health Systems, Economic Evaluations, Quality of Life 4

Co-authors: Georgia L. Wiesner Heather Hampel Robin L. Bennett Rachel Pearlman Alanna Kulchak Rahm Lori A. Orlando Geoffrey S. Ginsburg Vincent C. Henrich
Cited by: Genetics Cancer Research Pathology and Forensic Medicine
Partner nations: United States Canada Singapore

In The Last Decade

Adam H. Buchanan

75 papers receiving 1.9k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2014 A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment

Peers

Countries citing papers authored by Adam H. Buchanan

Since Specialization

Citations

This map shows the geographic impact of Adam H. Buchanan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam H. Buchanan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam H. Buchanan more than expected).

Fields of papers citing papers by Adam H. Buchanan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam H. Buchanan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam H. Buchanan. The network helps show where Adam H. Buchanan may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Adam H. Buchanan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Adam H. Buchanan Line = papers co-authored together Adam H. Buchanan links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Genomic Screening at a Single Health System Juliann M. Savatt,Melissa Kelly,Amy C. Sturm,Cara Z. McCormick,Marc S. Williams,Michelle Pistner Nixon,David D.K. Rolston,Natasha T. Strande,Karen E. Wain,Huntington F. Willard,W. Andrew Faucett,David H. Ledbetter,Adam H. Buchanan,Alastair J. Martin	2025	5
2	Pre-malignant conditions diagnosed following a positive cancer signal from a multi-cancer early detection test Omair A. Choudhry,Angana Banerjee Kharge,Seema P. Rego,Paul Z. Elias,Adam H. Buchanan,Anne Marie Lennon,Nickolas Papadopoulos,Frank Diehl,Tomasz M. Beer	2024	1
3	Evaluation of Malignant Hyperthermia Features in Patients with Pathogenic or Likely Pathogenic RYR1 Variants Disclosed through a Population Genomic Screening Program Kristen Yu,Megan Betts,G Urban,M. Schwartz,Tanisha O. Robinson,Robert J. Moyer,Scott W. Taddonio,Anasuya Vasudevan,Alicia Johns,Amy C. Sturm,Melissa Kelly,Marc S. Williams,S. Mark Poler,Adam H. Buchanan	2023	6
4	202P Participant perceptions and mammography adherence from DETECT-A: The first prospective interventional trial of a multi-cancer early detection (MCED) blood test Nickolas Papadopoulos,Anne Marie Lennon,P. Elias,S. Cillero Rego,Omair A. Choudhry,Darl D. Flake,Joshua D. Cohen,Christopher Douville,Ashley Honushefsky,Isaac Kinde,Alison P. Klein,Zachary Salvati,Cristian Tomasetti,Edward H. Wagner,Christina Barbara Walter,Elliot K. Fishman,Kenneth W. Kinzler,Bert Vogelstein,Tomasz M. Beer,Adam H. Buchanan	2023	1
5	Low adenoma burden in unselected patients with a pathogenic APC variant Rachel Schwiter,Heather Rocha,Alicia Johns,Juliann M. Savatt,David L. Diehl,Melissa Kelly,Marc S. Williams,Adam H. Buchanan	2023	1
6	Clinical validation of genomic functional screen data: Analysis of observed BRCA1 variants in an unselected population cohort Kelly M. Schiabor Barrett,Max Masnick,Kathryn E. Hatchell,Juliann M. Savatt,Natalie Banet,Adam H. Buchanan,Huntington F. Willard	2022	5
7	A RE-AIM Framework Analysis of DNA-Based Population Screening: Using Implementation Science to Translate Research Into Practice in a Healthcare System Laney K. Jones,Natasha T. Strande,Evan M. Calvo,Jingheng Chen,Gabriela Rodriguez,Cara Z. McCormick,Miranda L. G. Hallquist,Juliann M. Savatt,Heather Rocha,Marc S. Williams,Amy C. Sturm,Adam H. Buchanan,Russell E. Glasgow,Christa Lese Martin,Alanna Kulchak Rahm	2022	13
8	Defining the Critical Components of Informed Consent for Genetic Testing Kelly E. Ormond,Maia J. Borensztein,Miranda L. G. Hallquist,Adam H. Buchanan,W. Andrew Faucett,Holly L. Peay,Maureen E. Smith,Eric P. Tricou,Wendy R. Uhlmann,Karen E. Wain,Curtis R. Coughlin	2021	18
9	Positive impact of genetic counseling assistants on genetic counseling efficiency, patient volume, and cost in a cancer genetics clinic Miranda L. G. Hallquist,Eric P. Tricou,Michael N. Hallquist,Juliann M. Savatt,Heather Rocha,Alyson Evans,Nicole M Deckard,Yirui Hu,H. Lester Kirchner,Josie Pervola,Alanna Kulchak Rahm,Misha Rashkin,Tara Schmidlen,M. Schwartz,Janet L. Williams,Marc S. Williams,Adam H. Buchanan	2020	28
10	Design and Reporting Considerations for Genetic Screening Tests Jill Hagenkord,Birgit Funke,Emily Qian,Madhuri Hegde,Kevin B. Jacobs,Matthew J. Ferber,Matthew S. Lebo,Adam H. Buchanan,David Bick	2020	17
11	Developing a conceptual, reproducible, rubric-based approach to consent and result disclosure for genetic testing by clinicians with minimal genetics background Kelly E. Ormond,Miranda L. G. Hallquist,Adam H. Buchanan,Danielle Dondanville,Mildred K. Cho,Maureen E. Smith,Myra I. Roche,Kyle B. Brothers,Curtis R. Coughlin,Laura Hercher,Louanne Hudgins,Seema M. Jamal,Howard P. Levy,Misha Raskin,Melissa Stosic,Wendy R. Uhlmann,Karen E. Wain,Erin Currey,W. Andrew Faucett	2018	38
12	TOOLS AND TECHNOLOGY TO PROMOTE STUDENT CENTERED LEARNING AND ASSESSMENT Sajitha Kalathingal,Adam H. Buchanan	2017	3
13	Adherence to Recommended Risk Management among Unaffected Women with a BRCA Mutation Adam H. Buchanan,Corrine I. Voils,Joellen M. Schildkraut,Catherine A. Fine,Nora Horick,P. Kelly Marcom,Kristi Wiggins,Celette Sugg Skinner	2016	28
14	Randomized trial of DVD, telephone, and usual care for increasing mammography adherence Victoria L. Champion,Susan M. Rawl,Sara A. Bourff,Kristen M. Champion,Lisa Smith,Adam H. Buchanan,Laura J. Fish,Patrick O. Monahan,Timothy E. Stump,Jeffery K. Springston,Wambui G. Gathirua-Mwang,Celette S. Skinne	2016	0
15	Alternate Service Delivery Models in Cancer Genetic Counseling: A Mini-Review Adam H. Buchanan,Alanna Kulchak Rahm,Janter L. Williams	2016	87
16	Underestimation of Risk of a BRCA1 or BRCA2 Mutation in Women With High-Grade Serous Ovarian Cancer by BRCAPRO: A Multi-Institution Study Molly S. Daniels,Sheri A. Babb,Robin H. King,Diana L. Urbauer,Brittany Batte,Amanda Brandt,Christopher I. Amos,Adam H. Buchanan,David G. Mutch,Karen H. Lu	2014	22
17	Implementing family health history risk stratification in primary care: Impact of guideline criteria on populations and resource demand Lori A. Orlando,R. Ryanne Wu,Christopher A. Beadles,Tiffany Himmel,Adam H. Buchanan,Karen Powell,Elizabeth R. Hauser,Vincent C. Henrich,Geoffrey S. Ginsburg	2014	37
18	Providing patient education: impact on quantity and quality of family health history collection Christopher A. Beadles,R. Ryanne Wu,Tiffany Himmel,Adam H. Buchanan,Karen Powell,Elizabeth R. Hauser,Vincent C. Henrich,Geoffrey S. Ginsburg,Lori A. Orlando	2014	23
19	Protocol for implementation of family health history collection and decision support into primary care using a computerized family health history system Lori A. Orlando,Elizabeth R. Hauser,Carol A. Christianson,Karen Powell,Adam H. Buchanan,Blair Chesnut,Astrid B Agbaje,Vincent C. Henrich,Geoffrey S. Ginsburg	2011	43
20	Process outcomes from a randomized controlled trial comparing tailored mammography interventions delivered via telephone vs. DVD Celette Sugg Skinner,Adam H. Buchanan,Victoria L. Champion,Patrick O. Monahan,Susan M. Rawl,Jeffrey K. Springston,Qianqian Zhao,Sara A. Bourff	2010	12

About Adam H. Buchanan

Adam H. Buchanan is a scholar working on Genetics, Pathology and Forensic Medicine and Oncology, having authored 77 papers that have together received 2.0k indexed citations. Recurring topics across this work include BRCA gene mutations in cancer (45 papers), Genomics and Rare Diseases (23 papers), Genetic factors in colorectal cancer (17 papers), Ethics in Clinical Research (14 papers), Colorectal Cancer Screening and Detection (13 papers), Global Cancer Incidence and Screening (13 papers), Cancer Genomics and Diagnostics (8 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). The work is most often cited by research in Genetics (1.2k citations), Cancer Research (387 citations) and Pathology and Forensic Medicine (358 citations). Adam H. Buchanan has collaborated with scholars based in United States, Canada and Singapore. Frequent co-authors include Georgia L. Wiesner, Heather Hampel, Robin L. Bennett, Rachel Pearlman, Alanna Kulchak Rahm, Lori A. Orlando, Geoffrey S. Ginsburg, Vincent C. Henrich, Celette Sugg Skinner and Karen Powell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact